Janux Therapeutics (JANX) Change in Account Payables (2020 - 2026)
Janux Therapeutics (JANX) posted quarterly Change in Account Payables of -$1.6 million for Q1 2026, up 1.53% year-over-year from -$1.6 million in Q1 2025, and down 196.58% quarter-over-quarter from $1.7 million in Q4 2025.
Janux Therapeutics (JANX) Change in Account Payables (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported Change in Account Payables for 7 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 1.53% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at $1.0 million (up 148.64% YoY), while the FY2025 annual figure was $977000.0, down 38.32% from the prior year.
- Change in Account Payables slipped to -$1.6 million in Q1 2026 per JANX's latest filing, from $1.7 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.7 million in Q4 2025 and bottomed at -$1.6 million in Q1 2025.
- Historically, Change in Account Payables has averaged $54823.5 across 5 years, with a median of -$107000.0 in 2023.
- On a YoY basis, Change in Account Payables climbed as much as 415.35% in 2024 and fell as far as 326.17% in 2024.
- Janux Therapeutics' Change in Account Payables stood at $223000.0 in 2022, then jumped by 46.64% to $327000.0 in 2023, then surged by 376.76% to $1.6 million in 2024, then advanced by 7.06% to $1.7 million in 2025, then slumped by 196.58% to -$1.6 million in 2026.
- Business Quant data shows JANX's Change in Account Payables at -$1.6 million in Q1 2026, $1.7 million in Q4 2025, and -$168000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Janux Therapeutics | 984.58 Mn | 984.58 Mn | - | -342,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -342,000.00 |
| Jun 30, 2026 | -342,000.00 |
| Mar 31, 2026 | -1.61 Mn |
| Mar 31, 2026 | -1.61 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | -168,000.00 |
| Sep 30, 2025 | -168,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | -694,000.00 |
| Jun 30, 2024 | -694,000.00 |
| Mar 31, 2024 | -456,000.00 |
| Mar 31, 2024 | -456,000.00 |